Peer Review History
| Original SubmissionJanuary 30, 2025 |
|---|
|
Dear Dr. Akinsolu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Francis Xavier Kasujja Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: I congratulate the authors for this very interesting manuscript. However I have some comments: 1. Methodology: at the search strategy and studies eligibility criteria, the authors mention studies that report the prevalence and patterns of substance use in West Africa (lines 94,95 and 111, 112). Could the authors clarify the link with the current research topic which is mobile phone follow-up? 2. Discussion: I think that the suggestion to use WhatsApp (and similar platforms) needs to be better explained by the authors. The limitation of such platforms is the necessity for the user to have a smartphone and access to internet, which is variable in SSA, with limited access for people from low socioeconomic background and/or living in rural areas. Reviewer #2: Overall this is an interesting article and a lot of effort was put into the analysis. It is however somewhat lacking in the discussion area and claims to share more insight than it does. 1. In the abstract and the text you write that: “Retention rates were highest in Kenya (96%) and Nigeria (87%), while countries like Cameroon reported a loss rate of 42%.” and “Risk of bias assessments revealed that 81% of observational studies were low risk, while 69% of experimental studies were rated high quality.” I would suggest both sentences be made into two sentences for clarity – otherwise the reader tries to compare retention and loss, or risk and high quality. 2. The Search strategy and Studies Eligibility Criteria both mention West Africa – is it not SSA? 3. You mention in the methods and results sections that text messages were sometimes included. It should be made clear in the abstract and introduction of the paper that text messages were included in some studies - text and phone calls use different software and sustain different human/tech costs. 4. Please also make clear if the phone calls were all via a health worker (human), an automated system or a combination of both. 5. Please define: Retention Rate, Acceptability, Feasibility, Follow-up Rates early in the paper 6. PICOS misspelled lines 114, 125, 129 7. Table 2: Can you please categorize the papers further? There is a column for ‘Study settings’. We need a column for type of health program e.g. chronic disease management, maternal health programs 8. You reference ‘mHealth infrastructure’ in lines 419 and 466. This is this something different than simply network connectivity’? Clarity needed. 9. Lines 425-426: you write ‘Conversely, infrequent follow-ups correlated with lower retention rates, emphasizing the dual importance of both frequency and quality of communication?’ There is nothing mentioned on quality – please clarify. 10. Line 431-433: you write “This review identified key barriers to implementing phone call follow-ups, including network connectivity issues, outdated or incorrect contact information, and participant relocations. These challenges, specific to resource-constrained environments, highlight the need for robust participant management strategies.” Are outdated and or incorrect contact information and participant relocations actually specific to resource-constrained environments? And can you give example(s) of a robust participant management strategy? 11. Line 435: you write “Additionally, integrating alternative communication platforms like WhatsApp could provide more accessible, cost effective options to improve follow-up success rates [70, 73-76].” This seems to be your big takeaway, so more needs to be added on why this is beneficial and how implementers could take this advice into account. 12. Line 463: You write “The study highlights actionable strategies to address barriers to retention, offering practical implications for policymakers and healthcare providers.” I do not think the discussion shares enough actionable strategies. More examples and context from the reviewed studies would strengthen this article. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Evaluating Phone Call Follow-Ups in Sub-Saharan Africa: A Systematic Review and Meta-Analysis PONE-D-25-04857R1 Dear Dr. Akinsolu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Francis Xavier Kasujja Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-25-04857R1 PLOS ONE Dear Dr. Akinsolu, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Francis Xavier Kasujja Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .